Thanks! This is restoring a bit of my trust in the EMA. I am afraid the guy should already look for his next job because I doubt his contract will be renewed, when time comes.
Isn't it obvious that people are a bit scared when they read (here: https:/www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-janssen-epar-product-inf ormation_en.pdf): "The safety and efficacy of COVID-19 Vaccine Janssen in children and adolescents (less than 18 years
of age) have not yet been established. No data are available." or "Interaction with other medicinal products and other forms of interaction
No interaction studies have been performed. Concomitant administration of COVID-19 Vaccine
Janssen with other vaccines has not been studied." (the latest point is not true, the Philippines did... but it was 'government' funded apparently... not enough for JandJ aparently:
https:www.philstar.com/headlines/2022/01/10/2152809/dost-funded-covid-19-vaccine-mix-and-match-stu dy-underway)

In fact the other vaccines have also not been studied for interaction with other medicinal products. (Corminary aka Pfizer, https:www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf )

But apparently we are expected to 'suspend judgment' and  stop reading miindications

Also, we are still using these under "conditional authorization"
https:/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-cov id-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised